Evidence map›Paper›PMID 35862681›Full record

ArticleJournal of virology2022

The Host Response to Influenza A Virus Interferes with SARS-CoV-2 Replication during Coinfection.

Kohei Oishi, Shu Horiuchi, Judith M Minkoff, Benjamin R tenOever

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
10.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 69 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. The impact of COVID-19 pandemic on the etiological spectrum of respiratory infections in children.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2025
    Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Kohei OishiDepartment of Microbiology, New York University, New York, New York, USA.ORCID 0000-0002-2995-7856
Shu HoriuchiDepartment of Microbiology, New York University, New York, New York, USA.
Judith M MinkoffDepartment of Microbiology, New York University, New York, New York, USA.
Benjamin R tenOeverDepartment of Microbiology, New York University, New York, New York, USA.ORCID 0000-0003-0324-3078
New York University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and influenza A virus (IAV) represent two highly transmissible airborne pathogens with pandemic capabilities. Although these viruses belong to separate virus families-SARS-CoV-2 is a member of the family

Indexed as

CoinfectionCOVID-19Cross-PrimingInfluenza A Virus, H1N1 SubtypeInfluenza, HumanSARS-CoV-2Virus ReplicationAnimalsHumansInterferonsMesocricetusInterferonsanosmiaendemicH1N1host responseinterferenceinterferonlong COVIDpandemicPASCRNA sequencing

Identifiers

PMID35862681
PMCPMC9364782
OpenAlexW4285040844

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.